Role of COX-2 in tumorospheres derived from a breast cancer cell line

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages

  Singh, Balraj ^a   Cook, Kendra R ^a   Vincent, Laura ^a   Hall, Carolyn S ^a   Martin, Cecilia ^a   Lucci, Anthony ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

breast cancer; cancer stem like cell; COX 2; disseminated tumor cell; inflammatory breast cancer; tumorosphere

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PYRAZOLES; RECEPTORS, ESTROGEN; SULFONAMIDES;

EID: 79955616732     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.03.003     Document Type: Article

References (37)

1. Crawford YG, Gauthier ML, Joubel A, et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 2004;5:263.
2. Singh B, Vincent L, Berry JA, et al. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells. J Surg Res 2007;140:220.
3. Singh B, Cook KR, Vincent L, et al. Cyclooxygenase-2 induces genomic instability, BLC2 expression, doxorubicin resistance, and altered cancer-inhibiting cell phenotype in MCF7 breast cancer cells. J Surg Res 2008;147:240.
4. Singh B, Berry JA, Shoher A, et al. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 2005;26:1393.
5. Singh B, Berry JA, Vincent LE, et al. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. J Surg Res 2006;134:44.
6. Singh B, Berry JA, Shoher A, et al. COX-2 induces IL-11 production in human breast cancer cells. J Surg Res 2006;131:267.
7. Singh B, Berry JA, Shoher A, et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene 2007;26:3789.
8. Lucci A, Krishnamurthy S, Singh B, et al. Cylooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat 2009;117:61.
9. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353:793.
10. Fidler IJ, Kripke ML. Metastasis results from pre-existing variant cells within a malignant tumor. Science 1977;197:893.
11. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983.
12. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253.
13. Engelmann K, Shen H, Finn OJ. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008;68:2419.
14. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006;98:1777.
15. Li X, Lewis MT, Huang J, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008;100:672.
16. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008;10:R25.
17. Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumor dormancy. APMIS 2008;116:754.
18. Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006;12:5615.
19. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnol 2008;26:1269.
20. Kim JB, Zaehres H, Wu G, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008;454:646.
21. Cariati M, Naderi A, Brown JP, et al. Alpha-6 integrin is necessary for the tumorigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008;122:298.
22. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506.
23. 2 protects mouse embryonic stem cells from apoptosis. Stem Cells 2007;25:1096.
24. 2 and peroxisome proliferator-activated receptor δ promotes mouse embryonic stem cells proliferation. Stem Cells 2008;26:745.
25. 2 regulates vertebrate hematopoietic stem cell homeostasis. Nature 2007;447:1007.
26. 2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009;136:1136.
27. Cha YI, DuBois RN. NSAIDs and cancer prevention: Targets downstream of COX-2. Annu Rev Med 2007;58:239.
28. 2 stimulates Id-1 transcription. J Biol Chem 2008;283:33955.
29. Poma P, Notarbartolo M, Labbozzetta M, et al. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis. Int J Mol Med 2007;20:329.
30. Wright MH, Calcagno AM, Salcido CD, et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10. R10. Epub Feb 1.
31. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009;69:1302.
32. Bauerschmitz GJ, Ranki T, Kangasniemi L, et al. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. Cancer Res 2008;68:5533.
33. Spencer AG, Woods JW, Arakawa T, et al. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J Biol Chem 1998;273:9886.
34. Liou JY, Deng WG, Gilroy DW, et al. Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem 2001;276:34975.
35. Perrone G, Zagami M, Altomare V, et al. COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Arch 2007;451:1039.
36. Cauffman G, Liebaers I, Van Steirteghem A, et al. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 2006;24:2685.
37. Xiao Y, Ye Y, Yearsley K, et al. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 2008;173:561.